Lazard Capital Downgrades Amgen (AMGN) to Sell
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $438.12 +1.92%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Lazard Capital downgraded Amgen (NASDAQ: AMGN) from Neutral to Sell with a price target of $58.00.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $69.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) call put ratio 1 call to 1.1 puts
- JPMorgan Downgrades Huaxia Bank Co Ltd (600015:CH) to Underweight
- JPMorgan Downgrades Industrial Bank Co Ltd (601166:CH) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
